The Novel Compound SUL-138 Counteracts Endothelial Cell and Kidney Dysfunction in Sepsis by Preserving Mitochondrial Function

Sepsis is defined as a dysregulated host response leading to organ dysfunction, which may ultimately result in the patient's death. Mitochondrial dysfunction plays a key role in developing organ dysfunction in sepsis. In this study, we explored the efficacy of the novel mitochondrial protective compound, SUL-138, in sepsis models in HUVECs and mice. In LPS-challenged HUVECs, SUL-138 preserved mitochondrial membrane potential and oxygen consumption and limited mitochondrial oxidative stress, resulting in increased survival at 48 h. Further, SUL-138 dampened the LPS-induced expression of IL-1β, but not of NLRP3, and IL-18 in HUVECs. Sepsis in mice induced by cecal ligation and puncture (CLP) led to a lower mitochondrial membrane potential and increased levels of mitochondrial oxidative stress in the kidney, which SUL-138 limited. In addition, SUL-138 mitigated the CLP-induced increase in kidney dysfunction markers NGAL and urea. It dampened the rise in kidney expression of IL-6, IL-1β, and ICAM-1, but not TNF-α and E-selectin. Yet, SUL-138 limited the increase in plasma levels of IL-6 and TNF-α of CLP mice. These results demonstrate that SUL-138 supports mitochondrial function, resulting in a limitation of systemic inflammation and preservation of kidney function.

Medienart:

E-Artikel

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Zur Gesamtaufnahme - volume:24

Enthalten in:

International journal of molecular sciences - 24(2023), 7 vom: 28. März

Sprache:

Englisch

Beteiligte Personen:

Star, Bastiaan S [VerfasserIn]
van der Slikke, Elisabeth C [VerfasserIn]
van Buiten, Azuwerus [VerfasserIn]
Henning, Robert H [VerfasserIn]
Bouma, Hjalmar R [VerfasserIn]

Links:

Volltext

Themen:

AKI
Endothelial cells
Interleukin-6
Journal Article
Lipopolysaccharides
Metabolism
Mitochondria
Oxidative stress
SUL-138
Sepsis
Tumor Necrosis Factor-alpha

Anmerkungen:

Date Completed 14.04.2023

Date Revised 15.04.2023

published: Electronic

Citation Status MEDLINE

doi:

10.3390/ijms24076330

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM355516624